Intimation regarding non-applicability of Regulation 23(9)
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Brawn Biotech Ltd has informed BSE that it is exempt from Regulation 23(9) of SEBI LODR, which requires disclosure of related party transactions. The company qualifies for this exemption under Regulation 15(2) because its paid-up share capital is Rs. 3 Crores and net worth is Rs. 4.32 Crores (approx.), both below the specified thresholds of Rs. 10 Crore and Rs. 25 Crore respectively. The company states this exemption has applied for the last three consecutive financial years. This is a routine regulatory compliance filing confirming the company's eligibility for the exemption.
No direct impact on shareholders or stock price. This filing simply confirms the company remains a small listed entity exempt from certain disclosure requirements. It indicates the company has paid-up capital below Rs. 10 crore and net worth below Rs. 25 crore, classifying it as a small/micro cap stock.